The Positively Quit Trial for Smoking Cessation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of South Florida

About this trial

The main goal of the present study is to determine if a smoking cessation program designed for people living with certain chronic conditions and delivered via videoconferencing groups works better than a control condition--a program that is not designed to help with smoking but that does have the same number of group contact hours as the other program (this program is called the Attention Matched Control condition; AMC) for helping people with certain health conditions stop smoking. People in both groups will receive brief advice to quit and an offer of nicotine replacement therapy patches (NRT), as well as 12 videoconferencing group sessions. The team will measure smoking behavior over a one-year period and compare smoking rates for the treatment condition against AMC to see if the treatment condition is better at getting people living with certain health conditions to quit smoking.

Eligibility criteria

Qualifiers

greater than or equal to age 18 (as NRT is not FDA approved for adolescents)

self-report smoking cigarettes

positive cotinine test

motivated to quit

Disqualifiers

pregnant, breastfeeding, or have other contraindications to NRT

receiving other tobacco treatment, or

inability to communicate coherently in English during the video-conferencing test or other pre-enrollment interactions

Trial design

Treatments tested in this trial

  • Positively Me
  • Positively Living

Treatment groups

482 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of South Florida

Lead sponsor

National Cancer Institute (NCI)

Collaborator